Allianz Biotechnologie R EUR/  DE000A2AMPU5  /

Fonds
NAV2/27/2024 Chg.+1.1100 Type of yield Investment Focus Investment company
163.2300EUR +0.68% paying dividend Equity Allianz Gl.Investors 

Funds documents

Date Document Year Language Filesize
2/28/2024 Public WebStation Live Factsheet 2024 English -
11/29/2023 PREN20231129-0002009594.pdf 2023 English 300.34 KB
11/29/2023 PRDE20231129-0002008436.pdf 2023 German 256.27 KB
9/29/2023 Prospectus 2023 German 560.09 KB
6/30/2023 Semi-annual report 2023 English 127.19 KB
6/30/2023 Semi-annual report 2023 German 115.13 KB
12/31/2022 Account statment 2022 English 185.10 KB
12/31/2022 Account statment 2022 German 173.02 KB
9/13/2022 Key Investor Information 2022 English 76.38 KB
9/13/2022 Key Investor Information 2022 German 76.84 KB
7/25/2022 Prospectus 2022 English 650.16 KB